Literature DB >> 3112375

Polyfunctional properties of hybridoma lupus anticoagulant antibodies.

J Rauch, H Tannenbaum, J L Senécal, A S Janoff, P R Cullis, M M Frojmovic.   

Abstract

Lupus anticoagulant antibodies are antiphospholipid antibodies which are characterized by their ability to prolong the clotting time in in vitro coagulation assays measuring the partial thromboplastin time (PTT). In our study, we have analyzed 11 hybridoma lupus anticoagulant antibodies and studied their reactivity with hexagonal and lamellar phospholipids, DNA, IgG, cytoskeletal components, and intact platelets. Our results demonstrate that hexagonal phase phospholipids but not lamellar phospholipids were able to neutralize the lupus anticoagulant activity of all 11 hybridoma antibodies. However, the lupus anticoagulant antibodies differed from one another in their reactivity with DNA, the Fc fragment of IgG, cytoskeletal proteins and platelets. Some of the lupus anticoagulant antibodies reacted with all of these structures, while others reacted with only some or none of the antigens tested. Isoelectric focusing gel analysis confirmed that this polyreactivity was due to a single antibody. Direct binding of lupus anticoagulant antibodies to intact platelets was shown to correlate with the DNA binding activity of the antibodies. Lupus anticoagulant antibodies were also capable of inducing a morphological shape change in platelets. Our data suggest that hybridoma lupus anticoagulant antibodies may react as lupus anticoagulant antibodies only, anti-DNA antibodies, rheumatoid factors, anticytoskeletal antibodies, and antiplatelet antibodies. The degree of overlap in these subgroups and the epitopes responsible for these multiple reactivities remain to be determined.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3112375

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  4 in total

Review 1.  Lessons about autoantibody specificity in systemic lupus erythematosus from animal models.

Authors:  D I Stott
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

2.  Monoclonal anticardiolipin antibodies derived from mice with experimental lupus erythematosus: characterization and the induction of a secondary antiphospholipid syndrome.

Authors:  Z M Sthoeger; B Tartakovsky; Z Bentwich; E Mozes
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

3.  Lupus anticoagulant antibodies inhibit collagen-induced adhesion and aggregation of human platelets in vitro.

Authors:  I Ostfeld; N Dadosh-Goffer; S Borokowski; J Talmon; A Mani; U Zor; J Lahav
Journal:  J Clin Immunol       Date:  1992-11       Impact factor: 8.317

4.  Anti-dsDNA and Sm autoantibodies in systemic lupus erythematosus.

Authors:  E Martínez-Cordero; E Martínez-Miranda; M C Negrete-García; A Padilla; D E Aguilar León
Journal:  Clin Rheumatol       Date:  1992-09       Impact factor: 2.980

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.